Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: coment

1. Aomar-Millán, I.F.
2. Salvatierra, J.
3. Callejas-Rubio, J.L.
4. Raya-Álvarez, E.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.REUMA.2022.01.003 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus